Histological, immunohistochemical, and genomic evaluation of excisional and diabetic wounds treated with human Wharton's jelly stem cells with and without a nanocarrier. Issue 7 (31st January 2019)

• Record Type: Journal Article
• Authors: Raj, Vaishnevi; Claudine, Stephanie; Subramanian, Arjunan; Tam, Kimberley; Biswas, Arijit; Bongso, Ariff; Fong, Chui‐Yee
• Is Part Of: Journal of cellular biochemistry. Volume 120:Issue 7(2019)
• Page Start: 11222
• Page End: 11240
• Publication Date: 2019-01-31
• Subjects: diabetic wounds -- excisional wounds -- gene expression -- histology and immunohistochemistry -- human Wharton's jelly stem cells -- nanoscaffold; Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.28398
• Languages: English
• ISSNs: 0730-2312

Abstract

Abstract: We showed in previous studies that human umbilical cord Wharton's jelly stem cells (hWJSCs) improved the healing rates of excisional and diabetic wounds in the mouse model. As an extension of those studies, we report here the more detailed quantitative histological, immunohistochemical, and genomic evaluation of biopsies from those excisional and diabetic wounds in an attempt to understand the mechanisms of the enhanced wound healing aided by hWJSCs. Bright‐field microscopic observations and ImageJ software analysis on histological sections of the excisional and diabetic wound biopsies collected at different time points showed that the thickness of the epidermis and dermis, and positive picrosirius‐red stained areas for collagen, were significantly greater in the presence of hWJSCs compared with controls ( P < 0.05). Immunohistochemistry of the diabetic wound biopsies showed increased positive staining for the vascular endothelial marker CD31 and cell proliferation marker Ki67 in the presence of hWJSCs and its conditioned medium (hWJSC‐CM). Quantitative real‐time polymerase chain reaction showed upregulation of groups of genes involved in extracellular matrix regulation, collagen biosynthesis, angiogenesis, antifibrosis, granulation, and immunomodulation in the presence of hWJSCs. Taken together, the results demonstrated that hWJSCs and hWJSC‐CM that contains the paracrine secretions of hWJSCs, enhance the healing of excisional and diabetic wounds via re‐epithelialization, collagen deposition, angiogenesis, and immunomodulation. The inclusion of an Aloe vera ‐polycaprolactone (AV/PCL) nanocarrier did not significantly change the effect of the hWJSCs. However, the topical application of an AV/PCL nanocarrier impregnated with hWJSCs is convenient and less invasive than the administration of hWJSC injections into wounds. Abstract : Quantitative histological, immunohistochemical, and genomic evaluation of biopsies taken from excisional and diabetic wounds treated with human Wharton's jelly stem cells (hWJSCs) or its conditioned medium (hWJSC‐CM) in the presence or absence of a nanocarrier enhance wound healing via re‐epithelialization, collagen deposition, angiogenesis, and immunomodulation. The results reinforce the enhanced wound healing properties of hWJSCs and hWJSC‐CM in the presence or absence of a nanocarrier.